Success Metrics

Clinical Success Rate
72.7%

Based on 8 completed trials

Completion Rate
73%(8/11)
Active Trials
0(0%)
Results Posted
50%(4 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_3
2
18%
Ph not_applicable
1
9%
Ph phase_2
3
27%
Ph phase_1
5
45%

Phase Distribution

5

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
5(45.5%)
Phase 2Efficacy & side effects
3(27.3%)
Phase 3Large-scale testing
2(18.2%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

72.7%

8 of 11 finished

Non-Completion Rate

27.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Terminated(3)

Detailed Status

Completed8
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
72.7%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (45.5%)
Phase 23 (27.3%)
Phase 32 (18.2%)
N/A1 (9.1%)

Trials by Status

terminated327%
completed873%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_1

Phase 1 Single Ascending Dose Study With ATX101

NCT07107802
completedphase_2

Study Assessing Pain Relief After Replacement of the Knee

NCT06799845
terminatedphase_2

Study Assessing Pain Relief After Replacement of the Knee

NCT05260008
terminatednot_applicable

Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat

NCT03284034
terminatedphase_2

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma

NCT05116683
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07107802Phase 1

Phase 1 Single Ascending Dose Study With ATX101

Completed
NCT06799845Phase 2

Study Assessing Pain Relief After Replacement of the Knee

Completed
NCT05260008Phase 2

Study Assessing Pain Relief After Replacement of the Knee

Terminated
NCT03284034Not Applicable

Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat

Terminated
NCT05116683Phase 2

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma

Terminated
NCT02123134Phase 3

Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age

Completed
NCT02163902Phase 3

Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Completed
NCT01462786Phase 1

To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101

Completed
NCT00618709Phase 1

Dose-Escalation Safety and Pharmacokinetic Study of ATX-101

Completed
NCT01319916Phase 1

Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

Completed
NCT00835952Phase 1

ATX-101 Abdominoplasty

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11